Tocilizumab Use in COVID-19 Cytokine-release Syndrome: Retrospective Study of Two Centers

INTRODUCTION: Cytokine-release syndrome (CRS) in COVID-19 patients can cause multiorgan failure and higher mortality. We used a structured protocol based on clinical, biochemical, and interleukin 6 (IL-6) criteria for the identification of the subset of patients with CRS and analyzed the use of toci...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasa, Prashant, Singh, Aanchal, Upadhyay, Surjya, Bagadia, Sukhant, Polumuru, Srinivasa, Shrivastava, Pavan K, Sankar, Rakesh, Vijayan, Lexy, Soliman, Mohamed A, Ali, Alaeldin, Patidar, Saroj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584850/
https://www.ncbi.nlm.nih.gov/pubmed/33132558
http://dx.doi.org/10.5005/jp-journals-10071-23566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584850/
https://www.ncbi.nlm.nih.gov/pubmed/33132558
http://dx.doi.org/10.5005/jp-journals-10071-23566

Ejemplares similares